for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Aprea Therapeutics Inc

APRE.O

Latest Trade

--

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

--

 - 

--

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Aprea Therapeutics Inc Qtrly Net Loss Per Share, Basic And Diluted $5.29

Nov 14 (Reuters) - Aprea Therapeutics Inc <APRE.O>::APREA THERAPEUTICS REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.APREA THERAPEUTICS INC - QTRLY NET LOSS PER SHARE , BASIC AND DILUTED $5.29.

Healthcap Vii Lp Reports 11.9 % Stake In Aprea Therapeutics

Oct 18 (Reuters) - Aprea Therapeutics Inc <APRE.O>::HEALTHCAP VII LP REPORTS 11.9 % STAKE IN APREA THERAPEUTICS AS OF OCTOBER 7, 2019 - SEC FILING.

Aprea Therapeutics Shares Debut about 3.1% over IPO price

Oct 3 (Reuters) - :APREA THERAPEUTICS SHARES OPEN AT $15.46 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $15 PER SHARE.

Aprea Therapeutics Announced Pricing Of Its IPO Of 5.7 Mln Shares At $15.00 Per Shr

Oct 2 (Reuters) - Aprea Therapeutics Inc <APRE.O>::APREA THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SHARES ARE EXPECTED TO BEGIN TRADING ON NASDAQ GLOBAL SELECT MARKET ON OCTOBER 3, 2019, UNDER TICKER SYMBOL "APRE.".ANNOUNCED PRICING OF ITS INITIAL PUBLIC OFFERING OF 5.7 MILLION SHARES OF ITS COMMON STOCK AT A PRICE OF $15.00 PER SHARE.

Aprea Therapeutics Sees IPO Of 5 Mln Shares Priced To Be Between $14 And $16 Per Share

Sept 23 (Reuters) - Aprea Therapeutics Inc <APRE.O>::APREA THERAPEUTICS INC SEES IPO OF 5 MILLION SHARES PRICED TO BE BETWEEN $14 AND $16 PER SHARE – SEC FILING.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up